Bionovate Technologies Corp. (BIIO) Financial Statements (2026 and earlier)

Company Profile

Business Address GEWERBESTRASSE 10
CHAM, 6330
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 364 - Electric Lighting And Wiring Equipment (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
ASSETS
Current Assets
Noncurrent Assets
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:265,825252,554251,130230,324211,290192,328
Accounts payable31,95433,87847,47938,13825,70221,757
Accrued liabilities     131,909116,892
Other undisclosed accounts payable and accrued liabilities233,871218,676203,651192,18653,67953,679
Debt185,375185,375185,375185,375 183,375
Due to related parties52,00945,70915,4683,840  
Other undisclosed current liabilities     185,375 
Total current liabilities:503,209483,638451,973419,539396,665375,703
Noncurrent Liabilities
Total liabilities:503,209483,638451,973419,539396,665375,703
Equity
Equity, attributable to parent(503,209)(483,638)(451,973)(419,539)(396,665)(375,703)
Common stock7754,5604,5605,9425,9425,942
Additional paid in capital2,300,8002,297,0152,297,0152,295,6332,295,6332,293,633
Accumulated deficit(2,804,784)(2,785,213)(2,753,548)(2,721,114)(2,698,240)(2,675,278)
Total equity:(503,209)(483,638)(451,973)(419,539)(396,665)(375,703)

Income Statement (P&L) (USD)
Annual | Quarterly

9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
Operating expenses(4,376)(16,685)(20,688)(3,622)(5,945)(2,748)
Operating loss:(4,376)(16,685)(20,688)(3,622)(5,945)(2,748)
Nonoperating expense(15,195)(14,980)(11,746)(19,252)(17,017)(21,390)
Other nonoperating expense(15,195)(14,980)(11,746)(19,252)  
Interest and debt expense(15,195)(15,026)(11,464)(19,252)(133,916)21,600
Loss from continuing operations before income taxes:(34,766)(46,691)(43,898)(42,126)(156,878)(2,538)
Other undisclosed income (loss) from continuing operations15,19515,02611,46419,252133,916(21,600)
Loss from continuing operations:(19,571)(31,665)(32,434)(22,874)(22,962)(24,138)
Loss before gain (loss) on sale of properties:(19,571)(31,665)(32,434)(22,874)(22,962)(24,138)
Net loss available to common stockholders, diluted:(19,571)(31,665)(32,434)(22,874)(22,962)(24,138)

Comprehensive Income (USD)
Annual | Quarterly

9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
Net loss:(19,571)(31,665)(32,434)(22,874)(22,962)(24,138)
Other undisclosed comprehensive loss (44,748)   (39,814) 
Comprehensive loss, net of tax, attributable to parent:(64,319)(31,665)(32,434)(22,874)(62,776)(24,138)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: